Highlights Dicot AB

Equities

DICOT

SE0011178458

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
0.257 ^SEK	+3.21%		-3.02%	-19.18%

05-06	Dicot AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-23	Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dicot AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-06	CI
Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	04-23	CI
Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	03-11	CI
Dicot AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-26	CI
Dicot AB Presents Positive Results from the First Part of its Phase 1 Clinical Study	01-23	CI
Dicot Files New Manufacturing Technology Patent in Sweden; Stock Rises	01-11	MT
Dicot Applies for Patent Covering New Manufacturing Technology	01-11	CI
Dicot AB Announces Partial Results from Phase 1 Trial to Be Presented Early Next Year	12-15	CI
Dicot AB Initiates Repeat Dosing in its Clinical Study	11-14	CI
Dicot AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/10/23	CI
Dicot AB Initiates Repeated Dosing in Phase I Study	24/10/23	CI
The Second Part of Dicot's Phase 1 Study Starts on October 20, 2023	20/10/23	CI
Swedish Pharma Company Dicot Files Application under Patent Cooperation Treaty	26/09/23	MT
Dicot AB Applies for International Patent Protection	26/09/23	CI
Dicot AB Announces First Participants Dosed in Phase 1 Trial	04/09/23	CI
Dicot AB Applies for US Patent	29/08/23	CI
Dicot AB Announces Clinical Phase 1 Study Starts	25/08/23	CI
Dicot AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23	CI
Dicot AB Receives Approval to Start Phase 1 Clinical Trial	15/08/23	CI
Dicot AB Submits Application to Start Clinical Phase 1 Trial	01/06/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Dicot AB

Equities

DICOT

SE0011178458

Highlights

Filters